Izzet Rozanes

Izzet Rozanes

Auto-generated profile, based on publicly available information

Izzet Rozanes

Koç University İşBank Center for Infectious Diseases, Koç University Hospital, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2003 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
EDEsen Deryani
Esen Deryani
SASemih Aki
Semih Aki
LMLutfiye Muslumanoglu
Lutfiye Muslumanoglu
IRIzzet Rozanes
Izzet Rozanes
Deryani E, et al. Yonsei Med J. 2003 Feb;44(1):27-32. http://dx.doi.org/10.3349/ymj.2003.44.1.27

1 August 2021 in European Journal of Radiology
Verified
Journal Article
Closed access
MVMetin Vural
Metin Vural
BCBilgen Coskun
Bilgen Coskun
MKMert Kilic
Mert Kilic
SDSelahattin Durmaz
Selahattin Durmaz
TGTerman Gumus
Terman Gumus
IRIzzet Rozanes
Izzet Rozanes

11 March 2023 in Infectious Diseases and Clinical Microbiology
Verified
Journal Article
Open access
FPFatihan Pınarlık
Fatihan Pınarlık
ŞKŞiran Keske
Şiran Keske
IRIzzet Rozanes
Izzet Rozanes
Onder ErgonulOnder Ergonul
Onder Ergonul
A 57-year-old female patient presented with fever, nausea, vomiting, loss of appetite, and weight loss within the last two months. Ceftriaxone and metronidazole therapy was started upon discovery of a liver abscess but provided no benefit. Following the of abscess biopsy, the patient developed fever, itching, anemia, acute renal failure, hyperbilirubinemia, and eosinophilia that required intensive care unit (ICU) admission. The Fasciola hepatica antibodies were detected by enzyme-linked immunosorbent assay (ELISA). Triclabendazole was started, after which the symptoms and magnetic resonance imaging (MRI) findings regressed. Even without eosinophilia, F. hepatica should be considered in cases with a liver abscess that does not respond to antibiotics. Keywords: Fascioliasis, Fasciola hepatica, liver abscess, triclabendazole